ID
int64
1
9.11k
age
float64
18
102
death
int64
0
1
sex
stringclasses
2 values
hospdead
int64
0
1
slos
int64
3
343
d.time
int64
3
2.03k
dzgroup
stringclasses
8 values
dzclass
stringclasses
4 values
num.co
int64
0
9
edu
float64
0
31
income
stringclasses
4 values
scoma
float64
0
100
charges
float64
1.17k
1.44M
totcst
float64
0
633k
totmcst
float64
-102.72
711k
avtisst
float64
1
83
race
stringclasses
5 values
sps
float64
0.2
99.2
aps
float64
0
143
surv2m
float64
0
0.97
surv6m
float64
0
0.95
hday
int64
1
148
diabetes
int64
0
1
dementia
int64
0
1
ca
stringclasses
3 values
prg2m
float64
0
1
prg6m
float64
0
1
dnr
stringclasses
3 values
dnrday
float64
-88
285
meanbp
float64
0
195
wblc
float64
0
200
hrt
float64
0
300
resp
float64
0
90
temp
float64
31.7
41.7
pafi
float64
12
890
alb
float64
0.4
29
bili
float64
0.1
63
crea
float64
0.1
21.5
sod
float64
110
181
ph
float64
6.83
7.77
glucose
float64
0
1.09k
bun
float64
1
300
urine
float64
0
9k
adlp
float64
0
7
adls
float64
0
7
sfdm2
stringclasses
5 values
adlsc
float64
0
7.07
7,301
46.76199
0
male
0
27
669
Coma
Coma
0
12
$25-$50k
41
78,762
51,755.75
59,276.25
20.5
white
16
19
0.751953
0.704956
13
0
0
no
0.8
0.8
no dnr
27
74
12
122
22
38
357.125
2.399902
3.5
1
135
7.429688
136
34
3,530
null
0
adl>=4 (>=5 if sur)
0
7,302
59.00299
0
male
0
25
668
ARF/MOSF w/Sepsis
ARF/MOSF
1
9
$11-$25k
0
37,381
26,401.8438
28,630.6875
9
white
30
73
0.648926
0.549927
16
0
0
no
0.85
0.85
no dnr
25
110
4
58
8
36.09375
285.6875
3.899902
1.099854
1
139
7.419922
141
22
1,645
4
4
SIP>=30
4
7,303
49.07599
0
female
0
28
668
ARF/MOSF w/Sepsis
ARF/MOSF
1
8
under $11k
0
76,917
50,563.75
55,395.375
32
white
23.5
32
0.806885
0.74292
22
0
0
no
0.9
1
no dnr
28
115
7.099609
72
20
35.39844
426.625
2.099609
0.399963
4.099609
142
7.429688
102
34
1,225
null
0
no(M2 and SIP pres)
0
7,304
43.76999
0
male
0
7
667
Cirrhosis
COPD/CHF/Cirrhosis
2
10
under $11k
0
6,435
4,384.043
5,108.82812
6
white
23.597656
30
0.823975
0.712891
1
0
0
no
0.8
0.7
no dnr
7
115
7.599609
68
24
36.19531
351.375
2.299805
0.299988
2.399902
129
7.359375
74
45
1,569
0
1
no(M2 and SIP pres)
1
7,305
49.65598
1
female
1
18
18
ARF/MOSF w/Sepsis
ARF/MOSF
2
10
under $11k
0
63,202
39,159.9062
43,919
43.333313
white
37.796875
58
0.613892
0.507935
1
0
0
no
0.8
0.8
no dnr
18
97
7.899414
60
20
36.29688
null
2.199707
0.399963
3.299805
136
null
157
43
2,450
null
1
<2 mo. follow-up
1
7,306
56.07397
1
female
1
9
9
MOSF w/Malig
ARF/MOSF
2
14
under $11k
0
12,176
7,825.1875
10,814.1094
35
white
37.195313
38
0.280945
0.171997
1
0
0
metastatic
0.4
0.2
dnr after sadm
2
68
18
104
24
36.59375
null
3.199707
0.399963
2
137
null
116
83
4,005
7
7
<2 mo. follow-up
7
7,307
77.68695
0
female
0
10
665
ARF/MOSF w/Sepsis
ARF/MOSF
1
10
under $11k
0
12,633
7,486.4531
8,704.75781
17
black
33.195313
55
0.56189
0.449951
1
0
0
no
0.9
0.8
no dnr
10
82
null
101
24
36.39844
null
3.899902
0.799927
1.299805
140
null
130
30
2,600
2
2
adl>=4 (>=5 if sur)
2
7,308
58.995
0
male
0
7
666
ARF/MOSF w/Sepsis
ARF/MOSF
0
8
$11-$25k
0
53,096
32,736.7812
37,951.875
25.5
white
27.796875
48
0.7229
0.636963
6
0
0
no
0.8
0.75
no dnr
7
60
29
144
32
39.19531
411.375
2.099609
1.899902
0.899902
135
7.509766
110
17
1,583
null
0
SIP>=30
0
7,309
51.73398
0
male
0
71
663
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
null
0
175,041
109,975.25
132,299.375
45.5
white
30.796875
34
0.709961
0.621948
4
0
0
no
0.9
0.9
no dnr
71
74
11.298828
55
24
35
263.3125
4.099609
1
1
142
7.439453
118
17
1,320
null
null
null
3.598633
7,310
69.54095
0
male
0
5
661
CHF
COPD/CHF/Cirrhosis
3
6
under $11k
0
8,421
4,101.3594
5,252.06641
20
black
17.796875
14
0.870972
0.786987
1
0
0
no
0.9
0.8
no dnr
5
117
14.798828
109
8
40.09375
186
2.699707
0.599976
8
134
7.419922
287
55
128
0
1
no(M2 and SIP pres)
1
7,311
54.25299
0
female
0
7
662
COPD
COPD/CHF/Cirrhosis
2
12
under $11k
0
13,297
null
null
20.5
white
22.699219
18
0.882935
0.803955
1
0
0
no
0.99
0.99
no dnr
7
104
10.798828
96
24
36.29688
200
2.899902
1.599854
1.199951
130
7.399414
85
17
null
0
1
no(M2 and SIP pres)
1
7,312
69.62897
1
male
1
7
7
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
under $11k
0
40,418
25,170.6562
28,908.2188
28.5
white
44.195313
105
0.29895
0.187988
1
0
0
no
0.1
0.1
no dnr
7
63
7.399414
109
16
38.69531
93.75
2.5
4.799805
0.699951
132
7.389648
228
19
2,093
null
2
<2 mo. follow-up
2
7,313
32.06799
1
male
0
6
584
Lung Cancer
Cancer
1
12
under $11k
0
5,519
3,775.5547
4,704.44922
13
white
16.898438
30
0.778931
0.53894
1
0
0
metastatic
0.8
0.5
no dnr
6
67
20.296875
79
24
38.59375
476.1875
2.799805
2
10.599609
133
7.439453
287
48
0
0
0
null
0
7,314
62.46399
0
female
0
11
660
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
under $11k
0
23,238
12,652.3984
14,606.3984
22.5
white
19.699219
30
0.865967
0.81897
1
0
0
no
0.9
0.85
no dnr
11
99
9.599609
80
20
36.09375
193.53125
4.799805
1.399902
1.399902
143
7.389648
263
10
800
1
0
SIP>=30
0
7,315
21.254
0
male
0
18
660
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
under $11k
44
27,953
19,023.1406
23,067.9375
20.666656
white
26
39
0.815918
0.753906
1
0
0
no
0.8
0.8
no dnr
18
10
10.199219
45
10
35.69531
440
2.699707
2.299805
1.5
132
7.429688
141
26
5,528
null
0
no(M2 and SIP pres)
0
7,316
73.31396
1
male
0
20
24
ARF/MOSF w/Sepsis
ARF/MOSF
3
null
under $11k
0
61,832
37,814.3125
43,382.625
41.333313
white
23.296875
43
0.73999
0.657959
1
1
0
yes
0.2
0.2
dnr after sadm
14
81
4.599609
70
24
36.69531
null
3.099609
0.599976
1.099854
131
null
73
31
null
null
0
<2 mo. follow-up
0
7,317
74.66095
0
female
0
19
660
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
under $11k
0
56,813
35,549.25
43,941.0312
39
white
41.5
77
0.343994
0.22699
1
0
0
no
0.2
0.15
no dnr
19
77
15.898438
78
22
35.59375
null
2.399902
0.5
3.699707
136
null
85
73
2,400
null
0
no(M2 and SIP pres)
0
7,318
69.74396
1
male
1
18
18
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$25-$50k
0
57,676
36,508.4062
41,565.75
38.333313
white
21.199219
28
0.787964
0.718994
1
0
0
yes
0.9
0.8
no dnr
18
126
12.298828
148
45
39.09375
197.5
2.299805
4
0.799927
126
7.389648
435
15
2,270
0
0
<2 mo. follow-up
0
7,319
74.93799
1
male
1
17
17
MOSF w/Malig
ARF/MOSF
4
null
under $11k
0
63,280
39,430.2812
45,698.25
40.666657
black
24.898438
42
0.492981
0.375
13
0
0
metastatic
0.9
0.3
dnr after sadm
12
51
13.798828
80
23
38
92.29688
2.599609
1.199951
1.299805
128
7.569336
373
36
2,124
null
6
<2 mo. follow-up
6
7,320
59.80298
0
female
0
15
657
COPD
COPD/CHF/Cirrhosis
3
null
under $11k
0
23,002
14,344.7812
16,834.25
21.333328
white
21.699219
33
0.836914
0.73291
1
0
0
yes
0.8
0.7
no dnr
15
105
9.199219
98
20
36.79688
null
4.099609
0.299988
1
133
null
108
8
1,975
null
6
SIP>=30
6
7,321
71.70697
1
male
1
17
17
Lung Cancer
Cancer
2
12
$25-$50k
9
27,936
18,377.7656
21,893.5469
23.666656
white
31.597656
56
0.254944
0.033997
1
0
0
metastatic
0.3
0.1
dnr after sadm
6
77
16.097656
72
24
36.5
138.75
3.099609
0.399963
1.199951
138
7.019531
114
34
1,575
null
0
<2 mo. follow-up
0
7,322
82.60394
1
female
1
6
6
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
null
0
42,766
26,497.6875
30,628.5469
83
white
50.09375
81
0.080994
0.030998
1
0
0
no
0.5
0.5
dnr after sadm
6
65
15.599609
71
26
35.89844
242.84375
null
null
1.599854
146
7.429688
202
48
null
null
0
<2 mo. follow-up
0
7,323
82.24799
0
male
0
10
656
ARF/MOSF w/Sepsis
ARF/MOSF
1
5
under $11k
0
12,879
8,194.1172
9,043.16406
13
black
18.199219
24
0.829956
0.772949
1
0
0
no
0.9
0.75
no dnr
10
61
16.796875
130
10
39
101.65625
2.799805
0.699951
1.099854
138
7.429688
176
17
605
0
0
SIP>=30
0
7,324
89.18799
1
female
1
4
4
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
$11-$25k
100
6,131
3,395.0547
3,806.05859
41
white
17.898438
42
0.328979
0.213989
1
0
1
yes
0.2
0.1
dnr after sadm
3
78
null
72
28
36.59375
null
null
null
null
140
null
null
null
null
null
null
<2 mo. follow-up
6.447266
7,325
53.03998
1
male
1
40
40
ARF/MOSF w/Sepsis
ARF/MOSF
2
8
$11-$25k
41
169,814
108,304.625
134,179.5
41.25
black
40.398438
78
0.212982
0.116989
11
0
0
no
0
0
dnr after sadm
31
52
3.399902
121
8
37.5
204
1.799805
0.5
0.699951
143
7.40918
165
12
2,700
null
1
<2 mo. follow-up
1
7,326
57.87
1
female
0
9
104
Colon Cancer
Cancer
2
12
under $11k
0
9,284
6,406.5234
7,780.69922
19.5
white
31
23
0.557983
0.235992
1
1
0
metastatic
0.2
0.1
no dnr
9
60
12.5
106
28
35.19531
null
2.599609
5.099609
0.799927
132
null
53
21
1,450
4
0
adl>=4 (>=5 if sur)
0
7,327
30.935
0
male
0
7
653
ARF/MOSF w/Sepsis
ARF/MOSF
4
11
under $11k
9
25,068
16,130.875
18,114.75
12
white
27.597656
60
0.817993
0.756958
4
0
0
no
0.3
0.2
no dnr
7
64
11.599609
131
60
38.39844
234.28125
2.299805
1.599854
0.799927
147
7.429688
261
18
3,870
1
0
no(M2 and SIP pres)
0
7,328
77.47797
1
female
0
11
171
ARF/MOSF w/Sepsis
ARF/MOSF
1
9
under $11k
0
20,604
10,068.4219
13,103.3594
26.5
white
15.798828
17
0.868896
0.822998
1
1
0
no
0.9
0.8
no dnr
11
99
9.599609
60
20
35.69531
null
null
1.099854
3.299805
135
null
233
68
1,150
0
null
no(M2 and SIP pres)
0.494751
7,329
72.01599
1
male
1
25
25
Coma
Coma
1
10
under $11k
0
182,796
119,558.625
148,157.375
29.5
white
27.898438
76
0.299988
0.22998
104
0
0
yes
0.2
0.1
no dnr
25
116
13.599609
77
37
38.39844
263.3125
2.5
1.799805
2.5
148
7.489258
318
32
1,777
null
6
<2 mo. follow-up
6
7,330
48.52597
0
male
0
39
650
ARF/MOSF w/Sepsis
ARF/MOSF
1
3
$11-$25k
37
93,397
60,183.6562
70,763.25
36
hispanic
25.296875
44
0.744995
0.664917
1
1
0
no
0.9
0.9
no dnr
39
135
6.799805
150
35
36.39844
112.23438
3.099609
0.799927
2.299805
131
7.379883
245
34
1,545
null
0
no(M2 and SIP pres)
0
7,331
22.89899
1
female
1
127
127
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
under $11k
9
245,362
153,695.375
170,105.125
37.25
white
36.398438
67
0.744995
0.664917
1
0
0
no
0.5
0.5
no dnr
127
67
11.5
116
10
38.09375
330
2.599609
1
0.699951
133
7.469727
217
12
3,254
null
6
adl>=4 (>=5 if sur)
6
7,332
41.50598
1
female
0
6
85
CHF
COPD/CHF/Cirrhosis
3
8
under $11k
0
8,695
5,518.0469
6,239.03906
21
white
27.597656
36
0.848999
0.750977
1
0
0
no
0.85
0.6
no dnr
6
97
10.099609
76
24
36.5
261.875
4
1.199951
0.799927
136
7.40918
163
14
null
0
0
SIP>=30
0
7,333
62.987
0
male
0
15
650
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
under $11k
0
21,499
14,114.6016
15,353.0859
15.666664
white
21.296875
38
0.810913
0.746948
1
1
0
yes
0.8
0.8
no dnr
15
79
15.599609
100
14
36
312
2.399902
0.299988
0.899902
131
7.369141
122
19
null
6
6
adl>=4 (>=5 if sur)
6
7,334
77.34198
0
male
0
7
648
CHF
COPD/CHF/Cirrhosis
7
7
under $11k
9
7,592
5,155.1758
5,114.14844
9
black
23.796875
32
0.738892
0.589966
1
0
1
no
0.4
0.2
no dnr
7
111
8.599609
80
34
34.79688
428.5625
2.799805
1.399902
0.699951
138
7.479492
128
7
null
null
2
adl>=4 (>=5 if sur)
2
7,335
36.57199
1
male
0
12
251
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
under $11k
0
26,524
16,549.5156
18,584.1875
35
black
21.296875
22
0.897949
0.860962
2
1
0
no
0.85
0.85
no dnr
12
89
8.398438
80
16
36.19531
null
4.5
0.699951
1.099854
139
null
138
19
null
6
6
SIP>=30
6
7,336
63.72598
0
female
0
8
644
ARF/MOSF w/Sepsis
ARF/MOSF
2
9
null
0
10,473
6,091.293
7,427.25781
15
white
25.398438
38
0.790894
0.721924
1
1
0
no
0.9
0.85
no dnr
8
120
21.097656
120
8
38.89844
203.3125
2.299805
0.399963
0.699951
146
7.399414
112
17
1,693
1
3
null
3
7,337
50.40698
1
male
1
4
4
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
under $11k
44
14,228
0
0
57
white
63.09375
143
0.001
0
1
0
0
no
0.02
0.01
no dnr
4
132
10.898438
72
10
38.39844
183.3125
2.699707
1.899902
1
139
7.469727
302
32
5,990
null
2
<2 mo. follow-up
2
7,338
56.64099
0
female
0
19
644
Coma
Coma
3
null
null
9
27,058
18,051
22,490.2969
28.333328
black
24.5
33
0.640991
0.580933
1
0
0
yes
0.6
0.6
no dnr
19
66
14.298828
119
10
38.69531
112
2
2.399902
1.399902
148
7.399414
74
26
3,252
null
7
adl>=4 (>=5 if sur)
7
7,339
89.00494
0
male
0
27
645
ARF/MOSF w/Sepsis
ARF/MOSF
0
8
under $11k
9
30,567
20,325.8438
23,380.1562
13
white
19.699219
13
0.761963
0.685913
1
0
0
no
0.5
0.5
dnr after sadm
11
54
0.099991
142
34
38.89844
140
2.899902
0.699951
7.599609
151
7.359375
167
130
655
null
2
adl>=4 (>=5 if sur)
2
7,340
67.98395
0
male
0
3
643
CHF
COPD/CHF/Cirrhosis
5
12
$11-$25k
0
2,880
1,813.3848
1,962.18945
null
white
15.298828
26
0.896973
0.827881
1
1
0
no
0.98
0.97
no dnr
3
102
7.5
71
22
36
null
4.099609
0.299988
1
133
null
114
27
46.796875
5
6
adl>=4 (>=5 if sur)
6
7,341
61.24597
1
male
1
5
5
MOSF w/Malig
ARF/MOSF
2
11
under $11k
9
6,452
4,052.2188
5,526.23828
19
black
20.199219
40
0.68689
0.593994
1
0
0
metastatic
0.2
0.05
dnr after sadm
2
75
8.898438
68
28
35.59375
null
4
1.699951
1.799805
136
null
84
43
null
null
0
<2 mo. follow-up
0
7,342
67.98895
1
male
1
10
10
Colon Cancer
Cancer
1
12
$11-$25k
9
11,578
7,914.1523
9,778.35938
16.5
white
30.097656
25
0.501953
0.181976
1
0
0
metastatic
0.6
0.3
dnr after sadm
7
93
4.199219
96
20
36.29688
371.375
3.399902
2.099609
2.299805
138
7.459961
107
41
null
4
4
<2 mo. follow-up
4
7,343
69.21594
0
male
0
8
640
CHF
COPD/CHF/Cirrhosis
4
11
under $11k
0
8,595
6,019.7344
6,605.46875
10.5
black
13.599609
32
0.907959
0.844971
1
1
0
no
0.5
0.1
no dnr
8
63
11.199219
110
30
35
null
4.399414
1.899902
1.899902
136
null
97
35
1,075
0
null
no(M2 and SIP pres)
0.494751
7,344
71.99695
1
male
1
12
12
COPD
COPD/CHF/Cirrhosis
3
7
under $11k
0
14,243
8,705.5938
9,856.15625
14
white
25.5
43
0.748901
0.603882
1
1
0
no
0.75
0.6
no dnr
12
124
8.699219
68
22
36.29688
null
3.899902
0.5
1.5
139
null
86
14
1,950
4
3
<2 mo. follow-up
3
7,345
72.03796
0
female
0
8
639
COPD
COPD/CHF/Cirrhosis
3
12
under $11k
0
12,585
7,749.5625
8,917.72656
10.5
white
18.199219
39
0.851929
0.755981
1
0
0
no
0.6
0.5
no dnr
8
91
9.5
96
22
36.39844
null
null
null
0.899902
134
null
88
9
null
1
0
no(M2 and SIP pres)
0
7,346
48.75
1
male
0
67
447
Coma
Coma
0
null
$11-$25k
100
87,147
58,913.9375
69,487.25
22.25
black
30.699219
53
0.105988
0.063995
9
0
0
no
0.1
0.1
dnr after sadm
2
116
10
124
28
38.59375
170
1.5
0.5
0.899902
134
7.399414
118
7
3,225
null
0
adl>=4 (>=5 if sur)
0
7,347
47.57599
1
male
1
17
17
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
under $11k
0
111,177
71,540.375
84,334.3125
55
white
31.5
48
0.66394
0.566895
39
0
0
no
0.1
0.1
dnr after sadm
14
117
7.399414
84
16
35.89844
null
3
0.399963
3.299805
133
null
156
36
2,830
null
null
<2 mo. follow-up
2.772461
7,348
52.38599
0
female
0
3
639
CHF
COPD/CHF/Cirrhosis
2
12
under $11k
0
2,328
1,536.1953
1,721.7998
null
white
19.597656
28
0.896973
0.826904
1
1
0
no
0.9
0.8
no dnr
3
131
13.599609
71
14
36.09375
359.25
null
null
0.5
134
7.419922
133
12
4,336
1
0
no(M2 and SIP pres)
0
7,349
35.38898
0
female
0
6
637
ARF/MOSF w/Sepsis
ARF/MOSF
1
14
under $11k
9
9,632
6,360.7422
6,905.67969
26
black
18.898438
13
0.912964
0.881958
1
0
0
no
0.85
0.8
no dnr
6
55
10.199219
199
10
39.39844
110
2
4.599609
2.099609
138
7.359375
116
42
1,124
null
0
no(M2 and SIP pres)
0
7,350
51.086
1
male
1
66
66
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
$11-$25k
9
215,577
139,854.75
165,144.125
49.25
white
29.398438
47
0.656982
0.55896
36
0
0
no
0.85
0.85
dnr after sadm
66
71
9.699219
56
8
36.89844
156.65625
3.199707
0.799927
1.799805
145
7.469727
162
44
1,523
null
0
SIP>=30
0
7,351
73.37396
1
female
1
29
29
Coma
Coma
0
6
under $11k
9
81,819
44,954.6562
56,661.6562
36.5
white
34.09375
75
0.202972
0.141998
8
0
0
no
0.1
0.05
dnr after sadm
2
54
6.899414
122
8
38.09375
173.3125
2.099609
0.699951
6.099609
137
7.399414
112
82
439
null
6
<2 mo. follow-up
6
7,352
31.93199
0
female
0
25
638
MOSF w/Malig
ARF/MOSF
2
11
under $11k
0
45,723
30,022.0938
36,584.2188
21
white
27
42
0.61792
0.512939
6
1
0
yes
0.65
0.6
no dnr
25
110
12.599609
69
8
38.39844
346
2.899902
0.5
0.699951
131
7.469727
120
17
3,158
0
1
no(M2 and SIP pres)
1
7,353
46.34399
0
male
0
16
633
COPD
COPD/CHF/Cirrhosis
1
11
under $11k
0
32,986
20,115.125
22,038.0781
29.666656
white
22.699219
27
0.901978
0.835938
2
0
0
no
0.8
0.7
no dnr
16
124
10.398438
104
24
36
257.125
null
0.399963
1.199951
133
7.429688
150
14
800
null
1
no(M2 and SIP pres)
1
7,354
44.64899
0
male
0
10
634
COPD
COPD/CHF/Cirrhosis
3
null
under $11k
0
15,277
9,645.8906
10,760.8359
13
white
22.5
28
0.915894
0.856934
1
0
0
no
0.9
0.8
no dnr
10
58
3.5
96
20
38.69531
null
null
null
1
139
null
143
4
2,250
0
3
no(M2 and SIP pres)
3
7,355
81.60199
1
female
0
3
114
CHF
COPD/CHF/Cirrhosis
3
null
under $11k
0
3,870
null
null
null
white
16.199219
23
0.817993
0.704956
1
1
0
yes
null
null
no dnr
3
108
8.898438
87
28
36.79688
269.5625
null
null
1.099854
136
7.339844
146
26
4,750
null
null
no(M2 and SIP pres)
2.711426
7,356
48.84299
0
male
0
19
633
COPD
COPD/CHF/Cirrhosis
3
12
under $11k
0
44,920
27,563.8125
31,555.9531
30
white
19.898438
23
0.920898
0.866943
1
0
0
no
0.9
0.85
no dnr
19
75
8
65
24
36.59375
null
3.299805
0.5
0.899902
137
null
141
19
null
null
0
no(M2 and SIP pres)
0
7,357
66.31598
0
female
0
16
632
COPD
COPD/CHF/Cirrhosis
2
8
under $11k
0
null
null
null
30
white
34.796875
43
0.601929
0.411987
1
0
0
no
0.55
0.5
null
null
61
113.59375
63
20
36.69531
null
null
null
2
129
null
76
39
1,650
null
0
no(M2 and SIP pres)
0
7,358
49.13599
1
female
0
14
94
Colon Cancer
Cancer
2
10
under $11k
0
16,748
11,049.1641
13,971.3281
9.333328
white
34.195313
36
0.503906
0.18399
1
0
0
metastatic
0.6
0.4
no dnr
14
131
8.599609
118
20
37
null
5
0.699951
0.699951
135
null
69
11
2,350
5
5
adl>=4 (>=5 if sur)
5
7,359
39.99197
0
male
0
12
631
ARF/MOSF w/Sepsis
ARF/MOSF
1
11
$11-$25k
0
25,774
14,531.3438
17,859.5156
32
white
21.398438
27
0.890991
0.851929
2
0
0
no
0.95
0.95
no dnr
12
126
11.099609
75
28
36.59375
385.125
3.699707
0.399963
1
137
7.439453
125
18
4,485
null
4
no(M2 and SIP pres)
4
7,360
64.38898
1
female
0
26
51
COPD
COPD/CHF/Cirrhosis
4
8
under $11k
0
42,764
27,070.0781
33,508.4375
18.75
white
27.898438
67
0.763916
0.625
1
1
0
no
0.85
0.8
no dnr
26
63
26.097656
122
24
35.19531
null
1.699951
0.599976
6
136
null
74
66
230
0
0
<2 mo. follow-up
0
7,361
50.22299
1
female
1
7
7
MOSF w/Malig
ARF/MOSF
2
11
under $11k
37
28,142
17,324.5156
21,791.2812
67
black
59.898438
112
0
0
1
0
0
metastatic
0.3
0.25
no dnr
7
77
23.097656
134
10
39
245
1.599854
0.399963
0.5
134
7.459961
117
6
3,925
null
6
<2 mo. follow-up
6
7,362
74.75397
1
male
0
95
335
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
37
222,934
140,409.75
164,863.375
38.75
white
28.5
48
0.40094
0.281982
29
0
0
no
0.3
0.2
no dnr
95
92
5.899414
100
20
36.89844
null
2.199707
10.398438
0.899902
133
null
95
8
3,720
null
null
null
3.972168
7,363
43.66098
1
female
0
6
117
Colon Cancer
Cancer
1
12
under $11k
0
8,078
5,345.1172
6,745.9375
14
hispanic
15.298828
11
0.870972
0.709961
1
0
0
metastatic
0.6
0.5
no dnr
6
70
27
126
12
36.59375
133.3125
2.599609
1.099854
3.299805
128
7.40918
347
66
1,089
1
4
adl>=4 (>=5 if sur)
4
7,364
71.77295
1
male
0
78
213
Coma
Coma
1
16
$11-$25k
55
154,189
87,083.3125
100,583.625
39.75
white
26.296875
51
0.297974
0.227997
1
0
0
no
0.5
0.4
no dnr
78
43
11.798828
120
28
35.5
295.1875
3.299805
0.5
0.599976
137
7.489258
112
16
3,275
null
0
adl>=4 (>=5 if sur)
0
7,365
67.71497
0
female
0
9
629
ARF/MOSF w/Sepsis
ARF/MOSF
4
12
under $11k
37
14,637
9,498.2578
10,442.7656
16.5
white
27
23
0.536987
0.421997
1
0
0
yes
0.6
0.5
no dnr
9
109
10.898438
122
26
35.89844
122.21875
2.5
1.199951
1.5
133
7.449219
71
42
2,400
null
0
no(M2 and SIP pres)
0
7,366
65.28094
0
male
0
14
628
MOSF w/Malig
ARF/MOSF
2
8
$11-$25k
37
27,779
17,367.5938
20,223.3125
22.666656
white
31.597656
38
0.320984
0.20697
1
1
0
yes
0.4
0.2
no dnr
14
127
12.798828
124
10
39.69531
184
2.099609
4.399414
1.299805
144
7.40918
189
31
1,478
null
0
no(M2 and SIP pres)
0
7,367
89.58197
1
male
0
10
179
Lung Cancer
Cancer
2
null
under $11k
9
7,092
4,953.8047
6,743.54688
6
black
20.898438
14
0.505981
0.184998
1
0
1
metastatic
0.1
0
dnr after sadm
2
114
17.796875
107
24
36.29688
292
3.399902
0.5
0.899902
137
7.179688
165
13
1,750
null
1
adl>=4 (>=5 if sur)
1
7,368
62.79498
0
male
0
9
626
COPD
COPD/CHF/Cirrhosis
0
12
under $11k
0
19,330
11,695.375
13,542.8828
23.5
white
23.5
35
0.835938
0.730957
1
0
0
no
0.7
0.6
no dnr
9
55
14.5
112
12
38.69531
120
null
null
0.699951
134
7.419922
105
7
3,385
null
0
no(M2 and SIP pres)
0
7,369
57.448
0
female
0
6
622
COPD
COPD/CHF/Cirrhosis
4
9
under $11k
0
8,879
5,460.3359
6,111.87891
10
white
10.699219
16
0.948975
0.912964
1
0
0
no
0.65
0.5
no dnr
6
100
7.5
118
24
36
null
4
1.299805
1.199951
136
null
100
14
null
0
0
SIP>=30
0
7,370
51.409
0
male
0
21
622
Cirrhosis
COPD/CHF/Cirrhosis
2
11
under $11k
0
52,650
null
null
36.333313
white
22.5
43
0.80188
0.679932
1
0
0
no
0.8
0.75
no dnr
21
83
13.298828
100
10
36.89844
158
4.099609
2.099609
0.599976
132
7.389648
116
13
2,690
null
0
SIP>=30
0
7,371
78.41199
1
male
0
80
274
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
under $11k
0
150,578
95,131.25
120,197.188
37
white
33.796875
60
0.449951
0.330994
8
0
0
no
0.6
0.6
no dnr
80
52
20.097656
128
28
40
106.65625
1.799805
3.399902
2.699707
134
7.299805
54
29
885
null
5
null
5
7,372
60.56897
0
male
0
18
621
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
under $11k
9
39,502
23,890.2812
26,963.125
27.333328
white
15.599609
27
0.86792
0.820923
6
0
0
no
0.8
0.7
no dnr
18
79
0.699951
71
24
36
null
3.399902
0.899902
0.899902
136
null
87
10
3,250
null
6
SIP>=30
6
7,373
69.69995
1
male
0
5
592
COPD
COPD/CHF/Cirrhosis
2
8
under $11k
0
6,091
3,742.6777
4,147.50781
18
white
19.699219
14
0.846924
0.747925
1
0
0
no
0.8
0.6
no dnr
5
66
16.296875
65
40
36.5
261.25
3.599609
0.599976
0.899902
138
7.40918
129
30
1,700
0
null
no(M2 and SIP pres)
0.494751
7,374
22.68599
0
female
0
32
621
ARF/MOSF w/Sepsis
ARF/MOSF
0
15
under $11k
0
113,240
70,633
84,378
41.75
black
32
65
0.793945
0.726929
7
0
0
no
0.2
1
no dnr
32
121
18.5
129
38
39
172.5
3.099609
0.899902
1.199951
141
7.379883
148
23
4,995
null
0
null
0
7,375
24.241
0
female
0
17
620
ARF/MOSF w/Sepsis
ARF/MOSF
0
14
under $11k
0
61,561
39,252.0312
47,995.4062
51.333313
white
38.296875
62
0.661987
0.564941
10
0
0
no
0.5
0.5
no dnr
17
71
15.298828
141
14
36.89844
238
2.699707
1.299805
1.599854
140
7.519531
158
35
2,860
null
0
no(M2 and SIP pres)
0
7,376
68.18896
1
female
0
9
237
COPD
COPD/CHF/Cirrhosis
2
null
$11-$25k
0
21,855
13,324.9297
15,247.8438
24
white
22.699219
26
0.816895
0.702881
1
0
0
no
0.8
0.7
no dnr
9
45
13.398438
127
10
35.89844
185
1.799805
8.298828
1.199951
145
7.389648
304
25
1,938
null
0
SIP>=30
0
7,377
64.63495
1
male
0
13
525
COPD
COPD/CHF/Cirrhosis
2
10
under $11k
9
23,165
14,729.3906
17,390.625
20.5
black
31.398438
42
0.623901
0.438965
3
0
0
no
0.85
0.75
no dnr
13
106
7.099609
100
32
35.59375
283.3125
3.599609
1.399902
1.299805
143
7.469727
213
28
2,600
null
1
no(M2 and SIP pres)
1
7,378
68.37195
1
female
0
7
551
CHF
COPD/CHF/Cirrhosis
3
3
under $11k
0
9,644
5,550.4375
6,353.39844
20
black
26.898438
37
0.755981
0.613892
1
0
0
no
0.8
0.7
no dnr
7
110
8.099609
141
30
36
177.5
2.599609
0.5
1.399902
144
7.419922
203
40
2,558
0
null
no(M2 and SIP pres)
0.494751
7,379
68.39398
0
female
0
21
618
COPD
COPD/CHF/Cirrhosis
3
10
under $11k
0
20,174
13,773.9844
15,103.9297
8.666664
white
20.398438
38
0.843994
0.744995
1
0
0
no
0.9
0.7
no dnr
21
132
22.296875
114
8
36.59375
140
3.399902
1
1.199951
140
7.429688
180
20
3,085
0
0
no(M2 and SIP pres)
0
7,380
75.81396
0
male
0
6
618
COPD
COPD/CHF/Cirrhosis
3
5
under $11k
0
10,247
6,206.1992
7,332.42969
27
white
27.199219
22
0.68396
0.515991
1
0
0
no
0.9
0.8
no dnr
6
61
0.599976
77
28
36.29688
null
2.299805
1.099854
1.5
128
7.489258
110
21
null
0
0
no(M2 and SIP pres)
0
7,381
77.90295
0
male
0
11
617
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
26
47,992
30,387.8594
36,794.7188
36
hispanic
23.699219
49
0.598999
0.491943
9
0
0
no
0.85
0.75
no dnr
11
36
35.5
118
10
36
140
1.099854
0.799927
2.599609
131
7.359375
211
48
1,935
null
0
no(M2 and SIP pres)
0
7,382
79.54797
1
male
1
58
58
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
>$50k
9
121,636
77,842.5625
96,503.1875
30.25
white
25
71
0.566895
0.454956
7
1
0
yes
0.7
0.7
dnr after sadm
44
76
36.398438
64
24
36.5
230
3.199707
1.399902
1.199951
137
7.529297
90
25
null
null
0
<2 mo. follow-up
0
7,383
79.67694
0
male
0
10
616
COPD
COPD/CHF/Cirrhosis
2
2
under $11k
9
9,488
6,038.7539
6,712.09766
7.5
hispanic
21.398438
33
0.675903
0.505981
1
0
0
yes
0.8
0.8
no dnr
10
105
11.099609
75
37
36.69531
298
2.599609
0.299988
1.399902
138
7.40918
244
48
1,280
0
0
no(M2 and SIP pres)
0
7,384
70.409
1
female
0
4
277
MOSF w/Malig
ARF/MOSF
2
12
$11-$25k
0
8,335
5,702.4609
7,194.39844
20
white
28
30
0.461975
0.342957
4
0
0
metastatic
0.6
0.35
no dnr
4
77
14.599609
77
14
36.29688
116
2.199707
9.599609
5.599609
127
7.339844
80
88
48
0
1
no(M2 and SIP pres)
1
7,385
66.146
1
female
1
11
11
Coma
Coma
0
12
under $11k
44
22,287
13,867.5391
15,568.0547
38
white
21.898438
30
0.539917
0.470947
1
0
0
no
0.3
0.2
dnr after sadm
9
109
10.298828
122
24
37
null
null
null
0.599976
119
null
321
7
4,450
null
0
<2 mo. follow-up
0
7,386
52.71997
1
female
1
13
13
Coma
Coma
3
12
null
44
25,744
16,137.1641
17,994.8438
31.5
white
29
35
0.472961
0.399963
1
0
0
no
0.15
0.1
dnr after sadm
10
132
15.099609
116
22
36.5
343.3125
null
1.299805
8.099609
132
7.449219
94
78
240
null
0
<2 mo. follow-up
0
7,387
72.20294
1
male
0
8
51
CHF
COPD/CHF/Cirrhosis
2
9
under $11k
9
14,810
8,979.4531
9,870.57812
19.5
black
27.398438
42
0.649902
0.471985
4
0
0
no
0.5
0.4
no dnr
8
69
13.099609
63
24
37.59375
268
3.699707
0.899902
1
139
7.209961
194
16
1,795
1
0
<2 mo. follow-up
0
7,388
30.508
0
male
0
35
613
MOSF w/Malig
ARF/MOSF
0
12
$25-$50k
0
63,693
42,754.375
54,207.4688
28
white
22.597656
26
0.738892
0.657959
3
0
0
yes
0.5
0.4
no dnr
35
62
19.597656
164
35
38.19531
126.65625
1.399902
0.5
1.299805
143
7.369141
57
64
2,025
0
0
SIP>=30
0
7,389
74.24194
0
male
0
4
613
CHF
COPD/CHF/Cirrhosis
6
11
$11-$25k
0
4,050
2,718.4883
3,112.57812
15
white
22.597656
16
0.797974
0.674927
1
1
0
no
1
0.75
no dnr
4
115
15.398438
117
10
38.59375
216.65625
2
0.799927
5.899414
141
7.319336
261
75
2,905
0
0
no(M2 and SIP pres)
0
7,390
21.681
0
male
0
24
613
ARF/MOSF w/Sepsis
ARF/MOSF
4
8
under $11k
41
null
null
null
31.666656
white
27
26
0.794922
0.727905
2
1
0
no
0.9
0.75
null
null
50
10.898438
141
30
38.89844
170
2.399902
0.5
0.599976
130
7.479492
217
10
1,469
null
6
adl>=4 (>=5 if sur)
6
7,391
59.12698
0
female
0
3
613
Cirrhosis
COPD/CHF/Cirrhosis
4
8
under $11k
0
2,768
1,807.0713
2,020.85938
null
white
26.898438
27
0.668945
0.495972
1
0
0
no
0.9
0.85
no dnr
3
47
7.299805
133
26
36.09375
422.1875
4
1.099854
0.899902
137
7.479492
98
14
1,200
null
null
no(M2 and SIP pres)
3.059082
7,392
75.15399
1
male
0
13
276
ARF/MOSF w/Sepsis
ARF/MOSF
1
8
$11-$25k
0
27,731
17,547.8125
19,428.3281
38.5
white
15.5
29
0.845947
0.793945
1
0
0
yes
0.1
0
dnr after sadm
7
114
13.5
113
20
36.39844
452
2.299805
0.399963
1.399902
144
7.299805
282
46
2,420
null
0
no(M2 and SIP pres)
0
7,393
52.31998
0
male
0
16
612
ARF/MOSF w/Sepsis
ARF/MOSF
0
16
$25-$50k
9
116,727
74,622.125
88,210.0625
34
white
27.398438
39
0.694946
0.603882
31
0
0
no
0.2
0.1
no dnr
16
100
5.199219
104
28
35.29688
null
4.099609
1
2
142
null
142
27
null
2
0
no(M2 and SIP pres)
0
7,394
79.52594
1
male
0
30
66
ARF/MOSF w/Sepsis
ARF/MOSF
3
7
under $11k
9
54,021
34,340
38,913.125
33.25
white
26.5
34
0.672974
0.576904
1
0
1
no
0.5
0.1
dnr before sadm
-1
66
8.699219
118
12
38.19531
377.5
2.699707
1.099854
0.199982
137
7.459961
86
12
1,969
null
6
null
6
7,395
65.78497
1
female
0
63
137
COPD
COPD/CHF/Cirrhosis
3
12
under $11k
0
147,956
80,905.9375
98,363.75
44.75
white
25.296875
39
0.794922
0.669922
1
0
0
no
0.7
0.7
no dnr
63
114
12.699219
72
20
35.59375
null
2.799805
1.699951
2
130
null
113
47
625
null
1
SIP>=30
1
7,396
46.77298
0
male
0
9
609
Cirrhosis
COPD/CHF/Cirrhosis
4
12
under $11k
0
14,136
9,081.2031
11,426.5391
23
white
25.097656
20
0.787964
0.659912
1
0
0
no
0.8
0.5
no dnr
9
26
68
200
43
36.29688
93
1.399902
4.5
2.5
139
7.189453
51
26
33
0
null
no(M2 and SIP pres)
0.494751
7,397
68.34796
0
male
0
14
610
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$11-$25k
0
36,287
19,190.4219
24,096.2812
34
white
25.597656
52
0.770996
0.696899
1
0
0
no
0.7
0.7
no dnr
14
115
24
122
40
38.59375
200
3.799805
0.5
0.799927
143
7.489258
181
14
3,230
null
1
no(M2 and SIP pres)
1
7,398
47.78598
0
male
0
5
608
ARF/MOSF w/Sepsis
ARF/MOSF
2
8
$11-$25k
0
6,856
4,204.9961
4,333.61719
45
white
27
31
0.822998
0.762939
1
1
0
no
0.9
0.9
no dnr
5
83
16.5
72
24
35.5
238.09375
2.5
0.899902
1.199951
148
7.539062
104
12
null
null
7
adl>=4 (>=5 if sur)
7
7,399
75.18396
1
female
1
4
4
Coma
Coma
0
18
$25-$50k
100
5,757
3,093.8828
3,786.69922
21
white
26.296875
43
0.078995
0.044998
1
0
0
no
0.1
0
dnr after sadm
1
87
10.298828
83
18
36.29688
152.375
4.199219
0.699951
1.099854
138
7.369141
170
24
null
null
null
<2 mo. follow-up
2.939453
7,400
78.57397
1
female
1
7
7
ARF/MOSF w/Sepsis
ARF/MOSF
0
14
under $11k
9
14,106
7,519.918
9,068.03906
25.5
black
30.898438
30
0.573975
0.462952
1
0
0
no
0.6
0.6
no dnr
7
104
19.5
110
24
36.39844
295.1875
2.399902
0.399963
1
146
7.519531
105
13
1,250
null
7
<2 mo. follow-up
7